Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthetic Approaches to New Drugs Approved During 2016
Andrew C. Flick, Hong X. Ding, Carolyn A. Leverett, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 16, pp. 7004-7031
Closed Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Small Molecule Kinase Inhibitor Drugs (1995–2021): Medical Indication, Pharmacology, and Synthesis
Cecilia C. Ayala-Aguilera, Teresa Valero, Álvaro Lorente‐Macías, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 2, pp. 1047-1131
Open Access | Times Cited: 193
Cu-Mediated Ullmann-Type Cross-Coupling and Industrial Applications in Route Design, Process Development, and Scale-up of Pharmaceutical and Agrochemical Processes
Qiang Yang, Yinsong Zhao, Dawei Ma
Organic Process Research & Development (2022) Vol. 26, Iss. 6, pp. 1690-1750
Closed Access | Times Cited: 168
Globally Approved EGFR Inhibitors: Insights into Their Syntheses, Target Kinases, Biological Activities, Receptor Interactions, and Metabolism
Mohammed A. S. Abourehab, Alaa M. Alqahtani, Bahaa G. M. Youssif, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6677-6677
Open Access | Times Cited: 132
FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application
Shuai Wang, Xiaohan Yuan, Saiqi Wang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 214, pp. 113218-113218
Closed Access | Times Cited: 109
Ullmann‐Ma Reaction: Development, Scope and Applications in Organic Synthesis†
Qian Cai, Wei Zhou
Chinese Journal of Chemistry (2020) Vol. 38, Iss. 8, pp. 879-893
Closed Access | Times Cited: 106
Continuous flow asymmetric synthesis of chiral active pharmaceutical ingredients and their advanced intermediates
Sándor B. Ötvös, C. Oliver Kappe
Green Chemistry (2021) Vol. 23, Iss. 17, pp. 6117-6138
Open Access | Times Cited: 83
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities
Marco Robello, Elisabetta Barresi, Emma Baglini, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 7, pp. 3508-3545
Open Access | Times Cited: 82
Artificial intelligence and automation in computer aided synthesis planning
Amol Thakkar, Simon Johansson, Kjell Jorner, et al.
Reaction Chemistry & Engineering (2020) Vol. 6, Iss. 1, pp. 27-51
Closed Access | Times Cited: 73
A decennary update on applications of metal nanoparticles (MNPs) in the synthesis of nitrogen- and oxygen-containing heterocyclic scaffolds
Tejas M. Dhameliya, Hiren A. Donga, Punit V. Vaghela, et al.
RSC Advances (2020) Vol. 10, Iss. 54, pp. 32740-32820
Open Access | Times Cited: 71
A comprehensive survey upon diverse and prolific applications of chitosan-based catalytic systems in one-pot multi-component synthesis of heterocyclic rings
Hossein Mousavi
International Journal of Biological Macromolecules (2021) Vol. 186, pp. 1003-1166
Closed Access | Times Cited: 49
Cooperative Rh/Chiral Phosphoric Acid Catalysis toward the Highly Stereoselective (3 + 3)-Cycloannulation of Carbonyl Ylides and Indolyl-2-methides
Henning Jakob Loui, Arun Suneja, Christoph Schneider
Organic Letters (2021) Vol. 23, Iss. 7, pp. 2578-2583
Closed Access | Times Cited: 45
Pd(II)-Catalyzed Enantioselective C(sp3)–H Arylation of Cyclopropanes and Cyclobutanes Guided by Tertiary Alkylamines
Jesus Rodrigalvarez, Luke A. Reeve, Javier Miró, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 9, pp. 3939-3948
Open Access | Times Cited: 30
Synthetic Approaches to the New Drugs Approved During 2020
Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 14, pp. 9607-9661
Closed Access | Times Cited: 29
Synthetic Approaches to the New Drugs Approved During 2017
Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 16, pp. 7340-7382
Closed Access | Times Cited: 54
Combining Cloud-Based Free-Energy Calculations, Synthetically Aware Enumerations, and Goal-Directed Generative Machine Learning for Rapid Large-Scale Chemical Exploration and Optimization
Phani Ghanakota, Pieter H. Bos, Kyle D. Konze, et al.
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 9, pp. 4311-4325
Open Access | Times Cited: 44
Electrochemical and Scalable Dehydrogenative C(sp3)−H Amination via Remote Hydrogen Atom Transfer in Batch and Continuous Flow
Pavlo Nikolaienko, Marc Jentsch, Ajit Prabhakar Kale, et al.
Chemistry - A European Journal (2019) Vol. 25, Iss. 29, pp. 7177-7184
Open Access | Times Cited: 43
Synthetic Approaches to the New Drugs Approved during 2019
Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 7, pp. 3604-3657
Closed Access | Times Cited: 36
Synthetic Approaches to the New Drugs Approved During 2021
Emma L. McInturff, Scott P. France, Carolyn A. Leverett, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10150-10201
Closed Access | Times Cited: 15
Pyridazine: A privileged scaffold in the development of 21st-century pesticides
Chao Chen, Geng Wang, Ke Li, et al.
Chinese Chemical Letters (2025), pp. 110902-110902
Closed Access
Description and In silico ADME Studies of US-FDA Approved Drugs or Drugs under Clinical Trial which Violate the Lipinski’s Rule of 5
Niyatha Lohit, Ankit Kumar Singh, Adarsh Kumar, et al.
Letters in Drug Design & Discovery (2023) Vol. 21, Iss. 8, pp. 1334-1358
Closed Access | Times Cited: 10
Recent advances in the design of small molecular drugs with acrylamides covalent warheads
Luxia Liang, Ze Zhang, Qidong You, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 112, pp. 117902-117902
Closed Access | Times Cited: 3
Pharmacological Chaperones for the Treatment of α-Mannosidosis
Rocío Rísquez‐Cuadro, Reimi Matsumoto, Fernando Ortega‐Caballero, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 12, pp. 5832-5843
Open Access | Times Cited: 29
Pentafluorophenyl Esters: Highly Chemoselective Ketyl Precursors for the Synthesis of α,α-Dideuterio Alcohols Using SmI2 and D2O as a Deuterium Source
Hengzhao Li, Yuxia Hou, Chengwei Liu, et al.
Organic Letters (2020) Vol. 22, Iss. 4, pp. 1249-1253
Closed Access | Times Cited: 25
Synthesis and clinical application of new drugs approved by FDA in 2022
Jingyi Zhang, Yatao Wang, Lu Sun, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top